¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"advanced glycosylation end product"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® advanced cancer ÇÑ±Û ÁøÇà¾Ï
¼³¸í   
  Á¶±â¾Ï¿¡ ´ëÇÑ ¸»·Î ¾ÏÀÇ °æ°ú°¡ ÁøÇàµÈ °ÍÀ» ¸»ÇÑ´Ù.
¿µ¹® blood product ÇÑ±Û Ç÷¾×Á¦Á¦
¼³¸í   
  1. »ç¶÷ÀÇ Ç÷¾×À» ¼ººÐº°·Î ºÐ¸®ÇÏ¿©, ±×°ÍÀ» ¿ø·á·Î Á¦Á¶ÇÑ ÀǾàǰ. ¾Ç¼º Á¾¾ç µûÀ§¿¡ ¼öÇ÷Çϴ ÀûÇ÷±¸, ¹éÇ÷º´-ÀÚ»ö¹Ýº´ÀÇ ÃâÇ÷À» ¸Ü°ÔÇϴ Ç÷¼ÒÆÇ, È­»óÀÇ Ä¡·á¿¡ ¾²´Â Ç÷Àå, »êÈÄ ÃâÇ÷À» ¸Ü°Ô Çϴ ¼¶À¯¼Ò¿ø µûÀ§°¡ ÀÖ´Ù. 2. »ç¶÷ÀÇ Ç÷¾×ÇüÀ» °Ë»çÇϴµ¥ ¾²´Â ¾à.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end product
    ÃÖÁ¾»ê¹°
  • glycosylation
    ´çÈ­
  • end-to-end anastomosis
    ³¡³¡¿¬°á(¼ú), ´Ü´Ü¿¬°á(¼ú)
  • end-to-end occlusion
    ³¡³¡¸Â¹°¸², ´Ü´Ü±³ÇÕ
  • advanced cancer
    ÁøÇà¾Ï
  • advanced cardiac life support
    »ó±Þ½ÉÀå¼Ò»ý¼ú, Àü¹®½ÉÀå¼Ò»ý¼ú
  • advanced pediatric life support
    »ó±Þ¼Ò¾Æ¼Ò»ý¼ú, Àü¹®¼Ò¾Æ¼Ò»ý¼ú
  • advanced sleep phase syndrome
    ÀüÁø¼ö¸éÀ§»óÁõÈıº
  • advanced trauma life support
    »ó±Þ¿Ü»ó¼Ò»ý¼ú, Àü¹®¿Ü»ó¼Ò»ý¼ú
  • assimilation product
    µ¿È­»ý¼º¹°
  • biological product
    »ý¹°ÇÐÀûÁ¦Á¦
  • blood product
    Ç÷¾×Á¦Á¦
  • degradation product
    ºÐÇØ»ê¹°
  • decay product
    ºØ±«»ê¹°
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°, ÇǺ기ºÐÇØ»ê¹°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end product
    ÃÖÁ¾»ê¹°
  • advanced cancer
    ÁøÇà¾Ï
  • glycosylation
    ´çÈ­
  • end organ
    Á¾¸»±â°ü
  • product
    »ý¼º¹°, »ê¹°
  • blood product
    Ç÷¾×Á¦Á¦
  • fibrinogen degradation products product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • fibrinogen degradation products product
    ¼¶À¯¼Ò¿øºÐÇØ»ê¹°
  • positive end expiratory pressure
    ³¯¼û³¡¾ç¾Ð, È£±â¸»¾ç¾Ð
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû
  • end-systolic volume
    ¼öÃà±â¸»¿ëÀû
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end product
    ÃÖÁ¾»ê¹°
  • glycosylation
    ´çÈ­
  • end to end anastomosis
    ³¡³¡¿¬°á(¼ú), ´Ü´Ü¿¬°á(¼ú)
  • end-to-end occlusion
    ³¡³¡¹°¸², ´Ü´Ü±³ÇÕ
  • advanced cancer
    ÁøÇà¾Ï
  • advanced sleep phase syndrome
    ÀüÁø¼ö¸éÀ§»óÁõÈıº
  • phase-advanced sleep
    À§»óÀüÁø¼ö¸é
  • assimilation product
    µ¿È­»ý»ê¹°
  • biological product
    »ý¹°ÇÐÀûÁ¦Á¦
  • blood product
    Ç÷¾×Á¦Á¦
  • pearson¡¯s product moment correlation
    ÇǾ»ó°ü°è¼ö
  • decay product
    ºØ±«»ê¹°
  • degradation product
    ºÐÇØ»ê¹°
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • intermediate product
    Áß°£»ê¹°, Áß°£´ë»ç¹°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • advanced glycosylation end products
    ÁøÇ༺´çÈ­Á¾¸»»ý¼º¹°(òäú¼àõÓÐûùðûØÇßæà÷Úª)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • addition product
    ºÎ°¡»ý¼º¹°(¡­ßæà÷Úª).
  • product costing
    Á¦Ç°°¡°Ý»êÁ¤
  • product of metabolism
    ´ë»ç»ê¹°(ÓÛÞóß§Úª).
  • advanced Fourier imaging
    Áøº¸ Fourier ¿µ»ó
  • advanced cancer
    ÁøÇà¾Ï(òäú¼ ).
  • advanced cardiac life support
    ÀÌÂ÷ (½ÉÆó)¼Ò»ý¼ú
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • advanced trauma life support
    »ó±Þ ¿Ü»ó¼Ò»ý¼ú
  • Krause s end bulbs
    Å©¶ó¿ìÁ¦Á¾¸»±¸.
  • Krauses end bulb
    Å©¶ó¿ìÁ¦Á¾¸»±¸
  • MEPP=>miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀü¾Ð
  • MEPP=£¾miniature end plate potential
    ¹Ì¼¼Á¾ÆÇÀüÀ§.
  • PEEP(positive end-expiratory pressure)
    È£±â¸» ¾ç¾ÐÈ£Èí
  • acromial end
    ºÀ¿ì¸®³¡
  • free end saddle partial denture
    À¯¸®´Ü±¹ºÎÀÇÄ¡.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • advanced glycosylation end products
    ÁøÇ༺´çÈ­Á¾¸»»ý¼º¹°(òäú¼àõÓÐûùðûØÇßæà÷Úª)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end product
    ÃÖÁ¾»ê¹°.»ýÈ­Á¾»ê¹°.
  • end-to-end anastomosis
    ´Ü´Ü¹®ÇÕ¼ú
  • end-to-end anastomosis
    ´Ü´Ü¹®ÇÕ¼ú.
  • end-to-end bite =e. occlusion
    ´Ü´Ü±³ÇÕ.
  • end-to-end implantation
    ´Ü´Ü»ðÀÔ¼ú
  • glycosylation
    ´çÈ­
  • glycosylation
    ´çÈ­, ±Û¶óÀÌÄÚ½ÇÈ­.
  • advanced Fourier imaging
    Áøº¸ Fourier ¿µ»ó
  • advanced cancer
    ÁøÇà¾Ï(òäú¼ ).
  • advanced cardiac life support
    ÀÌÂ÷ (½ÉÆó)¼Ò»ý¼ú
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • advanced trauma life support
    »ó±Þ ¿Ü»ó¼Ò»ý¼ú
  • moderately advanced tuberculosis
    Áߵ°áÇÙ(¡­Ì¿ú·).
  • phase-advanced sleep
    »óÀüÁø¼ö¸é(ßÓîñòäâ²Øù)
  • addition product
    ºÎ°¡»ý¼º¹°(¡­ßæà÷Úª).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Sternal end
    º¹À峡
    [¿¾ ¿ë¾î] Èä°ñ´Ü
  • Acromial end
    ºÀ¿ì¸®³¡
    [¿¾ ¿ë¾î] °ßºÀ´Ü
  • End piece
    ³¡ºÎºÐ
    [¿¾ ¿ë¾î] ¸»´ÜºÎ
  • End piece
    ³¡ºÎºÐ
    [¿¾ ¿ë¾î] Á¾¸»ºÎ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excretory-secretory product
    ºÐºñ¹è¼³¹°
  • apical end
    ÷´ÜºÎ
  • end group spine
    ±ê³¡°¡½Ã
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • advanced glycosylation end product
    ÁøÇà ´çÈ­Á¾»ê¹°(òäú¼ÓØûùðûß§Úª)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end product
    Á¾»ê¹°(ðûß§Úª)
  • end-product inhibition
    Á¾»ê¹° ÀúÇØ (ðûß§ÚªîÁúª)
  • end product repression
    Á¾»ê¹° ¾ïÁ¦ (ðûß§Úªåäð¤)
  • glycosylation
    ±Û¶óÀÌÄÚ½ÇÈ­(ûù)(Úãëë)
  • Amadori product
    ¾Æ¸¶µµ¸® »ý¼º¹°(ßæà÷Úª)
  • by-product
    ºÎ»ê¹°(Üùß§Úª)
  • gene product
    À¯ÀüÀÚ(ë¶îîí­) »ê¹°
  • product
    »ê¹°(ß§Úª)
  • product inhibition
    »ê¹°ÀúÇØ(ß§ÚªîÁúª)
  • solubility product
    ¿ëÇØµµ(éÁú°Óø) °ö
  • blunt end ligation
    µÐ´Ü¿¬°á(ÔïÓ®Ö§Ì¿)
  • blunt end
    µÐ´Ü(ÔïÓ®)
  • capped 5'-end
    ĸ °áÇÕ(Ì¿ùê)-5'-Á¾´Ü(ðûÓ®)
  • CCA-end
    CCA Á¾´Ü(ðûÓ®)
  • cohesive end
    Á¡ÂøÁ¾´Ü(ïÄó·ðûÓ®)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • advanced
    ÁøÇàµÈ, ÁøÇ༺
  • advanced Fourier imaging
    Áøº¸Fourier¿µ»ó
  • dairy product
    ³«µ¿»ê¹°
  • product
    »ê¹°, »ý¼º¹°
  • end artery
    Á¾µ¿¸Æ
  • hair on end pattern
    °ïµÎ¼±¸ð¹ßÇüÅÂ
  • upper end
    »ó¿¬
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AGE acrylamide gel; acute gastroenteritis; advanced glycation end product; agarose gel electrophoresis; ...
FDP fibrin degradation product; fibrinogen degradation product; flexor digitorum profundus; frontodextra...
JVP [POMD P 49 - 52]
  1) Jugular Vein Pressure
  2) Jugular Venous Pulse
...
EE embryo extract; end-to-end; end expiration; energy expenditure; Enterobacteriaceae enrichment [broth...
EP echo planar; ectopic pregnancy; edible portion; electrophoresis; electrophysiologic; electroprecipit...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AGE Advanced Glycosylation Endproducts
AGE Advanced Glycation End Products
AGE Advanced Glycosylated End-products
CDG Congenital Disorders of Glycosylation
glycation Glycosylation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • advanced glycosylation end products
    ÁøÇ༺ ´çÈ­ Á¾¸» »ý¼º¹°
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • advanced glycosylation end products
    ÁøÇ༺ ´çÈ­ Á¾¸» »ý¼º¹°
  • end to end relationship
    Àý´Ü¸é°ú Àý´Ü¸é °ü°è
  • end-to-end
    ³¡°ú ³¡ÀÌ Á¢ÇÑ, öÀúÈ÷, »ô»ôÀÌ
  • end-to-end bite
    ´Ü´Ü ±³ÇÕ
    µ¿ÀǾî=end-to-end occlusion.
  • end-to-end suture
    Àý´Ü´ë Àý´Ü ºÀÇÕ
  • advanced
    ÁøÇàµÈ, ÁøÇ༺
  • advanced cardiac life support
    ÀÌÂ÷ ¼Ò»ý¼ú, ÀÌÂ÷ ½ÉÆó¼Ò»ý¼ú
  • advanced Fourier imaging
    Áøº¸ Fourier ¿µ»ó
  • advanced stage
    ÁøÇà ¾ÇÈ­±â
  • biological product
    »ý¹°ÇÐÀû Á¦Á¦
  • blood product
    Ç÷¾× Á¦Á¦
  • by-product
    ºÎ»ê¹°, ºÎ»ý¹°
    Áֻ깰À» »ý»êÇÏ´Â °úÁ¤¿¡¼­ »ý±â´Â ÀÌÂ÷Àû »ê¹°.
  • degradation product
    ºÐÇØ »ê¹°
  • distortion product otoacoustic emission
    º¯Á¶ ÀÌÀ½Ç⠹ݻç
  • inflammatory by-product
    ¿°Áõ ºÎ»ê¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
glycosylation end products, advanced Products derived from the nonenzymatic reaction of glucose and proteins in vivo that exhibit a yellow-brown pigmentation and an ability to participate in protein-protein cross-linking. These substances are involved in biological processes relating to protein turnover and it is believed that their excessive accumulation contributes to the chronic complications of diabetes mellitus.
(12 Dec 1998)
end product <biochemistry> The final product of after a series of reactions with enzymes in a biochemical metabolic pathway has taken place.
(09 Oct 1997)
end product inhibition <biochemistry, physiology> The process of the end product of a particular metabolic reaction inhibiting an allosteric enzyme involved in that reaction as the reaction starts again, thus breaking the reaction cycle.
(09 Oct 1997)
end product repression Catabolite repression in which the catabolite is an end product of a particular pathway.
(05 Mar 2000)
glycosylation <biochemistry> The process of adding sugar units such as in the addition of glycan chains to proteins.
(18 Nov 1997)
end-to-end bite An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
end-to-end occlusion An occlusion in which the anterior teeth of both jaws meet along their incisal edges when the teeth are in centric occlusion.
Synonym: edge-to-edge bite, end-to-end bite, end-to-end occlusion.
(05 Mar 2000)
advanced concepts torus i <physics> A steady-state toroidal device built primarily for studies of RF heating and RF current drive.
Acronym: ACT I
(09 Oct 1997)
advanced fuels <radiobiology> There are several elements or isotopes that could be fused together, besides the DT fuel mixture. Many such fuel combinations would have various advantages over DT, but it is generally more difficult to achieve fusion with these advanced fuels than with the DT mix.
(09 Oct 1997)
advanced life support Definitive emergency medical care that includes defibrillation, airway management, and use of drugs and medications.
Compare: basic life support.
(05 Mar 2000)
advanced multiple-beam equalization radiography A variant of scanning equalization radiography using several X-ray beams.
(05 Mar 2000)
advanced toroidal facility <physics> A large stellarator device developed at Oak Ridge National Lab (ORNL), but now retired.
Acronym: ATF
(09 Oct 1997)
integrated advanced information management systems A concept, developed in 1983 under the aegis of and supported by the national library of medicine under the name of integrated academic information management systems, to provide professionals in academic health sciences centres and health sciences institutions with convenient access to an integrated and comprehensive network of knowledge. It addresses a wide cross-section of users from administrators and faculty to students and clinicians and has applications to planning, clinical and managerial decision-making, teaching, and research. It provides access to various types of clinical, management, educational, etc., databases, as well as to research and bibliographic databases. In august 1992 the name was changed from integrated academic information management systems to integrated advanced information management systems to reflect use beyond the academic milieu.
(12 Dec 1998)
activation product <radiobiology> The unstable nucleus formed when activation occurs. (See activation above.)
(09 Oct 1997)
by-product <chemistry> A product of a chemical reaction or industrial process which is different from the desired product.
(20 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • end product
    ¿¬¼Ó º¯È­ÀÇ ÃÖÁ¾°á°ú;ÃÖÁ¾ »ý¼º¹°
  • advanced
    ÀüÁøÇÑ
  • advanced
    Áøº¸ÇÑ;°íµîÀÇ;Áøº¸ÀûÀÎ
  • by-product
    ºÎ»ê¹°
  • product
    (º¹¼ö)»ý»ê¹°,¼º°ú
  • fission product
    Çٺп­ »ý¼º¹°
  • generic product
    »óÇ¥¾øÀÌ ÀϹݸíÀ¸·Î ÆÇ¸ÅµÇ´Â »óǰ
  • gross domestic product
    ±¹³» ÃÑ»÷»ê(GDP)
  • gross national product
    ±¹¹Î ÃÑ»ý»ê D
  • inner product
    ³»Àû
  • national product
    (°æ)(¿¬°£)±¹¹Î»ý»ê(cf.GNP)
  • net domestic product
    ±¹³» ¼ø»ý»ê
  • net national product
    ±¹¹Î¼ø»ý»ê
  • new product
    ½ÅÁ¦Ç°(»õ·Î¿î°ÍÀ¸·Î ÀÎÁ¤µÈ Á¦Ç° ¶Ç´Â ¼­ºñ½º)
  • parity product
    ÆÐ¸®Æ¼ Á¦Ç°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á